ProQR Therapeutics N.V. (PRQR)

ProQR Therapeutics Balance Sheet

Financials in millions EUR. Fiscal year is January - December.

Fiscal Year	TTM	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Sep 30, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Cash & Equivalents	89.4	118.93	94.78	187.52	75.84	111.95
Cash & Short-Term Investments	89.4	118.93	94.78	187.52	75.84	111.95
Cash Growth	-25.84%	25.48%	-49.46%	147.27%	-32.26%	6.03%
Accounts Receivable	-	-	56.25	-	-	-
Other Receivables	1.31	1.27	0.98	0.82	0.8	1.19
Receivables	1.31	1.27	57.24	0.82	0.8	1.19
Prepaid Expenses	1.71	0.79	2.45	3.14	3.38	1.53
Total Current Assets	92.41	120.99	154.46	191.48	80.02	114.67
Property, Plant & Equipment	14.44	16.9	16.24	17.47	18.6	2.44
Long-Term Investments	-	-	0.62	0.63	0.11	0.43
Total Assets	106.85	137.88	171.32	209.58	98.73	117.54
Accounts Payable	0.03	1.54	0.39	0.19	0.22	0.45
Accrued Expenses	1.37	1.66	1.12	1.23	6.15	8.92
Current Portion of Long-Term Debt	4.51	-	2.5	4.77	1.14	0.34
Current Portion of Leases	1.39	1.61	1.39	1.53	1.26	0.51
Current Income Taxes Payable	-	-	-	-	-	0.06
Current Unearned Revenue	24.86	20.57	5.64	5.12	0.7	0.71
Other Current Liabilities	7.48	8.82	9.95	14.76	0.84	-
Total Current Liabilities	39.64	34.2	20.99	27.6	10.3	10.99
Long-Term Debt	-	4.29	4.27	39.32	16.19	12.71
Long-Term Leases	11.5	13.83	13.81	14.75	15.69	-
Long-Term Unearned Revenue	30.73	44.17	65.57	14.69	-	-
Total Liabilities	81.87	96.49	104.64	96.35	42.18	23.7
Common Stock	3.37	3.37	3.37	3	2.17	2.16
Additional Paid-In Capital	413.07	412.89	412.54	398.31	288.76	287.21
Retained Earnings	-418.02	-400.85	-379.11	-317.77	-257.75	-211.75
Comprehensive Income & Other	26.57	25.98	30.26	30.3	23.92	16.7
Total Common Equity	24.98	41.39	67.07	113.83	57.09	94.33
Minority Interest	-	-	-0.38	-0.6	-0.55	-0.5
Shareholders' Equity	24.98	41.39	66.68	113.23	56.55	93.83
Total Liabilities & Equity	106.85	137.88	171.32	209.58	98.73	117.54
Total Debt	17.4	19.73	21.97	60.37	34.28	13.56
Net Cash (Debt)	72	99.19	72.8	127.15	41.56	98.39
Net Cash Growth	-27.47%	36.24%	-42.74%	205.94%	-57.76%	2.28%
Net Cash Per Share	0.88	1.22	1.02	1.98	0.83	2.40
Filing Date Shares Outstanding	81.68	81.35	80.82	71.29	50.2	49.75
Total Common Shares Outstanding	81.68	81.35	80.82	71.29	50.2	49.75
Working Capital	52.77	86.78	133.47	163.89	69.72	103.67
Book Value Per Share	0.31	0.51	0.83	1.60	1.14	1.90
Tangible Book Value	24.98	41.39	67.07	113.83	57.09	94.33
Tangible Book Value Per Share	0.31	0.51	0.83	1.60	1.14	1.90
Buildings	-	24.78	22.86	22.23	21.64	2.02
Machinery	-	5.91	4.91	4.25	3.63	2.98

Source: S&P Capital IQ. Standard template. Financial Sources.